Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Crossover studies with continuous variables: power analysis.

T J M Cleophas1, A H Zwinderman

  • 1Department of Medicine, Merwede Hospital Dordrecht, University Hospital Leiden, The Netherlands.

American Journal of Therapeutics
|January 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysis.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Regularized parametric survival modeling to improve risk prediction models.

Biometrical journal. Biometrische Zeitschrift·2023
Same author

A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity.

Allergy·2023
Same author

Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohort.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2022
Same author

Electrocardiogram-based mortality prediction in patients with COVID-19 using machine learning.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2022
Same author

Enhanced PeriOperative Care and Health protection programme for the prevention of surgical site infections after elective abdominal surgery (EPO<sub>2</sub>CH): statistical analysis plan of a randomised controlled multicentre superiority trial.

Trials·2021
Same journal

Abrocitinib as a Novel Therapeutic Option for Elastolytic Giant Cell Granuloma: A Case Report.

American journal of therapeutics·2026
Same journal

Dupilumab for Lichen Amyloidosis in an Elderly Multimorbid Patient.

American journal of therapeutics·2026
Same journal

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

American journal of therapeutics·2026
Same journal

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

American journal of therapeutics·2026
Same journal

Do Not Treat a Sequencing Report: Therapeutic Stewardship in Endometrial Microbiome Testing.

American journal of therapeutics·2026
Same journal

Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report.

American journal of therapeutics·2026
See all related articles

Crossover trial sensitivity depends on drug response correlation. Positive correlations enhance treatment effect detection, while negative correlations improve carryover/time effect detection in drug efficacy studies.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacology

Background:

  • Crossover designs minimize between-subject variability for drug efficacy assessment.
  • Potential issues include carryover effects, time effects, and negative correlations between treatment responses, which can reduce statistical power.

Purpose of the Study:

  • To explicitly study the power analysis of crossover trials with continuous variables.
  • To investigate how the correlation between drug responses impacts the sensitivity of crossover trial designs.

Main Methods:

  • Utilized the Scheffé model to assess treatment, carryover, and time effects.
  • Generated power curves for hypothetical crossover studies with varying correlations between drug responses.

Main Results:

Related Experiment Videos

  • The sensitivity of statistical testing in crossover trials is significantly influenced by the correlation between drug responses.
  • Positive correlations increase sensitivity for detecting treatment effects but decrease it for carryover/time effects.
  • Negative correlations show the opposite trend, increasing sensitivity for carryover/time effects.

Conclusions:

  • Correlation levels are a major determinant of testing sensitivity in crossover comparisons.
  • Crossover designs are well-suited for treatments with positive correlations (e.g., same drug class/action).
  • Trials comparing drugs from different classes/modes of action may benefit from considering negative correlation implications.